Ziying Yi

589 total citations
12 papers, 382 citations indexed

About

Ziying Yi is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Ziying Yi has authored 12 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Immunology and 4 papers in Cancer Research. Recurrent topics in Ziying Yi's work include Circular RNAs in diseases (4 papers), MicroRNA in disease regulation (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Ziying Yi is often cited by papers focused on Circular RNAs in diseases (4 papers), MicroRNA in disease regulation (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Ziying Yi collaborates with scholars based in China. Ziying Yi's co-authors include Guosheng Ren, Yushen Wu, Yunhai Li, Huimin Du, Long Wang, Bailin Niu, Hongzhong Li, Beilei Zeng, Xiaoyi Wang and Jiazheng Sun and has published in prestigious journals such as Nature Communications, Biochemical and Biophysical Research Communications and Frontiers in Immunology.

In The Last Decade

Ziying Yi

11 papers receiving 376 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ziying Yi China	10	223	162	130	94	44	12	382
Ana Rita Lourenço Netherlands	9	238 1.1×	106 0.7×	90 0.7×	84 0.9×	38 0.9×	11	383
Deli Mao China	8	243 1.1×	191 1.2×	105 0.8×	92 1.0×	74 1.7×	13	426
Hongjiu Ren China	13	240 1.1×	134 0.8×	79 0.6×	80 0.9×	41 0.9×	18	355
Joanna Poźniak Belgium	10	235 1.1×	71 0.4×	154 1.2×	118 1.3×	53 1.2×	18	406
Jacob Smigiel United States	7	196 0.9×	109 0.7×	251 1.9×	72 0.8×	38 0.9×	8	373
N. Ambartsumian Denmark	7	304 1.4×	131 0.8×	64 0.5×	103 1.1×	54 1.2×	9	390
Xiaozhang Xu China	4	181 0.8×	162 1.0×	61 0.5×	119 1.3×	29 0.7×	7	331
Ye‐Lin Liang China	12	410 1.8×	304 1.9×	104 0.8×	78 0.8×	54 1.2×	21	541
Erin D. Lucas Australia	8	163 0.7×	73 0.5×	125 1.0×	160 1.7×	25 0.6×	9	372

Countries citing papers authored by Ziying Yi

Since Specialization

Citations

This map shows the geographic impact of Ziying Yi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ziying Yi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ziying Yi more than expected).

Fields of papers citing papers by Ziying Yi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ziying Yi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ziying Yi. The network helps show where Ziying Yi may publish in the future.

Co-authorship network of co-authors of Ziying Yi

This figure shows the co-authorship network connecting the top 25 collaborators of Ziying Yi. A scholar is included among the top collaborators of Ziying Yi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ziying Yi. Ziying Yi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Wang, Xiaoyu, Jiakui Li, Yushen Wu, et al.. (2025). AEBP1 drives fibroblast-mediated T cell dysfunction in tumors. Nature Communications. 16(1). 8171–8171.

Wang, Pin, Ziying Yi, Yushen Wu, et al.. (2024). Blocking WNT7A Enhances MHC-I Antigen Presentation and Enhances the Effectiveness of Immune Checkpoint Blockade Therapy. Cancer Immunology Research. 13(3). 400–416. 4 indexed citations

Huang, Jiefeng, Jie Li, Jun Tang, et al.. (2022). ZDHHC22-mediated mTOR palmitoylation restrains breast cancer growth and endocrine therapy resistance. International Journal of Biological Sciences. 18(7). 2833–2850. 40 indexed citations

Wu, Yushen, Ziying Yi, Jie Li, et al.. (2022). FGFR blockade boosts T cell infiltration into triple-negative breast cancer by regulating cancer-associated fibroblasts. Theranostics. 12(10). 4564–4580. 64 indexed citations

Wang, Mengxue, Meng Dai, Yushen Wu, et al.. (2020). Immunoglobulin superfamily member 10 is a novel prognostic biomarker for breast cancer. PeerJ. 8. e10128–e10128. 12 indexed citations

Wu, Yushen, Beilei Zeng, Jiazheng Sun, et al.. (2020). CircEHMT1 inhibits metastatic potential of breast cancer cells by modulating miR-1233-3p/KLF4/MMP2 axis. Biochemical and Biophysical Research Communications. 526(2). 306–313. 40 indexed citations

Yi, Ziying, Yunhai Li, Yushen Wu, et al.. (2020). <p>Circular RNA 0001073 Attenuates Malignant Biological Behaviours in Breast Cancer Cell and Is Delivered by Nanoparticles to Inhibit Mice Tumour Growth</p>. OncoTargets and Therapy. Volume 13. 6157–6169. 31 indexed citations

Du, Huimin, et al.. (2019). The co-expression characteristics of LAG3 and PD-1 on the T cells of patients with breast cancer reveal a new therapeutic strategy. International Immunopharmacology. 78. 106113–106113. 68 indexed citations

Niu, Bailin, Fachun Zhou, Yanxin Su, et al.. (2019). Different Expression Characteristics of LAG3 and PD-1 in Sepsis and Their Synergistic Effect on T Cell Exhaustion: A New Strategy for Immune Checkpoint Blockade. Frontiers in Immunology. 10. 1888–1888. 38 indexed citations

10.

Wu, Yushen, et al.. (2019). A four-miRNA signature as a novel biomarker for predicting survival in endometrial cancer. Gene. 697. 86–93. 26 indexed citations

11.

Zeng, Beilei, Yunhai Li, Yixiao Feng, et al.. (2018). Downregulated miR-1247-5p associates with poor prognosis and facilitates tumor cell growth via DVL1/Wnt/β-catenin signaling in breast cancer. Biochemical and Biophysical Research Communications. 505(1). 302–308. 33 indexed citations

12.

Yi, Ziying, Dejuan Yang, Xuelian Liao, et al.. (2017). PSME3 induces epithelial–mesenchymal transition with inducing the expression of CSC markers and immunosuppression in breast cancer. Experimental Cell Research. 358(2). 87–93. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact